Search company, investor...

Henogen

Stage

Acquired | Acquired

Valuation

$0000 

About Henogen

Henogen is a Belgium-based viral vector manufacturing business.On January 15th, 2021, Henogen was acquired by Thermo Fisher.72M.

Headquarters Location

Rue des Professeurs Jeener et Brachet 12

Charleroi, 6401,

Belgium

+32 71 34 79 00

Missing: Henogen's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Henogen's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Henogen News

Belgium: Thermo Fisher acquires Henogen for €725m

Jan 25, 2021

LaingBuisson News By Thermo Fisher Scientific, the world’s largest maker of scientific instruments, is to acquire Belgian viral vector manufacturing business Henogen for €725m (US$880.3m) in cash. A subsidiary of Groupe Novasep, Henogen provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers from two locations in Seneffe and Gosselies. Founded more than 20 years ago, the business has approximately 400 employees with substantial operational and technical expertise in a broad range of viral vector classes and estimated 2020 revenues of €80m. “Novasep’s viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally,” said Michel Lagarde, executive vice president of Thermo Fisher. “The addition of their manufacturing capabilities in Europe complements our four development and manufacturing sites in North America. In addition, they bring an incredibly talented team with more than two decades of experience across a broad range of viral vectors,” he added explaining that the combination would benefit global customers seeking support and capacity in the region as well as European customers bringing new medicines to patients inside and outside of Europe. The business will be part of the pharma services business within the laboratory products and services segment. TAGS

Henogen Frequently Asked Questions (FAQ)

  • Where is Henogen's headquarters?

    Henogen's headquarters is located at Rue des Professeurs Jeener et Brachet 12, Charleroi.

  • What is Henogen's latest funding round?

    Henogen's latest funding round is Acquired.

  • Who are the investors of Henogen?

    Investors of Henogen include Thermo Fisher Scientific.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.